Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.5600
-0.0400 (-6.67%)
Mar 4, 2026, 4:00 PM EST
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $5.45 million as of March 5, 2026. Its market cap has decreased by -42.99% in one year.
Market Cap
5.45M
Enterprise Value
22.52M
Revenue
899.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.56
Market Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 5.45M, an increase of 2,056.58%. That is a compound annual growth rate of 21.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 5.45M | 454.99% |
| Dec 31, 2025 | 982.83K | -90.00% |
| Dec 31, 2024 | 9.83M | -38.42% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NKGen Biotech | 7.84M |
| Curative Biotechnology | 7.79M |
| Brainstorm Cell Therapeutics | 7.72M |
| TRON Group | 7.38M |
| AccuStem Sciences | 7.07M |
| Synlogic | 7.01M |
| BetterLife Pharma | 5.83M |
| Nymox Pharmaceutical | 5.17M |